In 1852, Rokitansky suggested that organized fibrin on vessel walls could cause atherosclerosis. Although this so-called "thrombogenic" hypothesis of atherosclerosis was denied by Virchow, Duguid revived this hypothesis in 1946.
In 1976, Ross and Glomset emphasized the importance of intimal smooth-muscle proliferation as the key element in the development of the advanced lesions of atherosclerosis. These two hypotheses suggest that hypercoagulability in a broad sense, including an enhanced platelet function and impaired fibrinolysis, may accelerate atherosclerosis. Recently, it has been shown that many risk factors of atherogenesis, such as an increase in LDL cholesterol, lipoprotein(a) and/or fibrinogen and a decrease in HDL cholesterol, enhances the platelet function while impairing fibrinolysis. The present article reviews these papers that have recently proposed supporting evidence for the “thrombogenic” or “response-to injury” hypothesis. These papers have presented conclusion such as: increased fibrinogen content in plasma enhances platelet aggregability; Apo A-I stabilizes prostacyclin which is a physiological antiplatelet substance in plasma; hyperlipidemia causes an increase in the plasminogen activator inhibitor (PAT), which is an important inhibitor of fibrinolysis in plasma; lipoprotein(a) which belongs to supergene family of plasminogen competitively impaires fibrinolysis.
The contribution of viral infection of the vascular endothelial cells to atherogenesis has also been discussed. The present article discusses the relationship between the latent infection of vascular cells with the herpes simplex virus and the “thormbogenic” or “response-to injury” hypothesis.
Relating to aging and hypercoagulable state, an increased procoagulant activity in cultured fibroblasts from progeria and Werner's syndrome of premature aging has been reported.
Recently, papers have suggested that the Alzheimer amyloid beta-protein precursor is identical to the platelet alpha granule protein. As a result of these studies, recent observations indicating that the frequency of Alzheimer's disease decreases in patients with rheumatoid arthritis are interesting, since aspirin or non-steroidal antiinflammatory drugs, frequently used in the cases of rheumatoid arthritis, suppress the platelet function.
Although there has been no direct evidence of the effectiveness of antithrombotic agents on the prevention of atherosclerotic diseases or Alzheimer's disease in man, this possibility should be further investigated.
View full abstract